Cargando…
Patients’ conceptions of their own influence on good treatment response to biological therapy in chronic inflammatory arthritis
BACKGROUND: Biological therapies are common in the treatment of patients with chronic inflammatory arthritis (CIA). However, despite the fact that many patients respond well to their biological therapies, there are still a number of nonresponders. In order to design the best care for patients, it is...
Autor principal: | Larsson, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495133/ https://www.ncbi.nlm.nih.gov/pubmed/28706444 http://dx.doi.org/10.2147/PPA.S131239 |
Ejemplares similares
-
The Diabetic Heart: Too Sweet for Its Own Good?
por: Whittington, Hannah J., et al.
Publicado: (2012) -
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy
por: Cerda, Osvaldo Luis, et al.
Publicado: (2019) -
A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial
por: Larsson, Ingrid, et al.
Publicado: (2015) -
For her own good. 150 years of the experts' advice to women
Publicado: (1979) -
Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars
por: Quinlivan, Alannah, et al.
Publicado: (2022)